Top Markets
Coin of the day
SeqLL Inc. SeqLL Inc.

SeqLL Inc.

SQL
Rang in Aktien #17413
Globally, SeqLL Inc. operates as a life sciences enterprise, providing... Globally, SeqLL Inc. operates as a life sciences enterprise, providing specialized instrumentation and research services. The company's primary focus involves the innovation, refinement, and production of cutting-edge genetic analysis technologies. Among its key offerings is the proprietary true single molecule sequencing (tSMS) platform, which facilitates the direct sequencing of DNA and RNA at the individual molecular level. SeqLL has established collaborative agreements with a range of esteemed organizations, including Bernstein Laboratory, Ting Laboratory, The Jackson Laboratory for Genomic Medicine, Weizmann Institute of Science, True Bearing Diagnostics, Inc., and Tetracore, Inc. Its diverse clientele encompasses academic institutions, governmental agencies, hospitals and medical centers, pharmaceutical and biotechnology companies, and various non-profit research groups. Established in 2013, the company maintains its headquarters in Billerica, Massachusetts.
Aktienkurs
$6.60
Zuletzt synchronisiert: 2025-02-06
Marktkapitalisierung
$242.77M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel SeqLL Inc. (SQL)

Kategorie

Aktien-Split-Historie für SeqLL Inc. (SQL)
Die Aktie SeqLL Inc. (Symbol: SQL) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Sep 02, 2026 statt.
Eine SQL-Aktie, die vor dem Sep 02, 2026 gekauft wurde, entspricht heute 0 SQL-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
8 x34
US
7 x47
US
0 -
CN
0 -
US
0 -
US